Recent News

Medicas Onco AI: Building a More Connected Future for Oncology Workflows

Dr. Hari Parameswaran shares the vision for an integrated AI platform designed to help oncology teams navigate clinical complexity and fragmented patient information.

Cancer care is becoming increasingly complex. Advances in diagnostics, treatment options, molecular profiling and precision medicine are generating more information than ever before. For oncologists, the challenge is not simply accessing this information. It is bringing it together, understanding it in context and using it to support clinical decision-making.

This is the challenge behind Medicas Onco AI, an integrated artificial intelligence platform being developed around the workflows of oncology teams.

In a new video, Dr. Parameswaran Hari, Chief Medical Officer of MC3 – Medicas Comprehensive Cancer Care, explains the thinking behind the platform and its vision for a more connected oncology ecosystem.

Moving Beyond Fragmented AI Tools

Oncology teams work with information from multiple sources, including clinical notes, pathology reports, medical imaging, laboratory investigations, treatment histories and molecular or genomic reports. These records may span years and involve several specialists.

Reviewing and interpreting this information in context can be demanding.

Medicas Onco AI is being developed with the aim of bringing multiple oncology workflows together within one platform, helping teams organise relevant information and navigate complex patient journeys more efficiently.

Rather than approaching every task as an isolated AI application, the platform's vision is to connect key activities across the oncology workflow.

Supporting the Oncology Team Across the Patient Journey

Medicas Onco AI is designed around several interconnected areas of oncology practice.

01

Patient Record Intelligence and Summarisation

The platform aims to bring together available patient records and create a structured view of the clinical history, diagnosis, investigations and treatment journey, helping clinicians navigate complex medical information.

02

Clinical Documentation

AI-supported documentation and patient summarisation aim to reduce the effort involved in reviewing and organising information, allowing clinicians to focus more of their attention on patient care.

03

Multidisciplinary Tumour Boards

Cancer management often involves medical oncologists, radiation oncologists, surgical oncologists, radiologists, pathologists and other specialists. Medicas Onco AI aims to support these discussions by making relevant patient information more structured and accessible.

04

Clinical Decision Support

The platform is being designed to help organise relevant clinical evidence and guidelines in context. Its intended role is to support the treating team's assessment and judgement, not replace the oncologist's clinical responsibility.

05

Clinical Trial Identification

Medicas Onco AI aims to support structured patient profiling and the identification of potentially relevant trial opportunities. Final eligibility and enrolment decisions remain with the relevant trial site and sponsor.

06

Precision Oncology and Genomics

As molecular and genomic information becomes increasingly important in cancer care, connecting these findings with the patient's broader clinical history can help teams review the case more comprehensively.

The broader vision also includes workflows involving patient navigation, research, analytics and care coordination.

The Living Digital Twin: A Connected View of the Patient

At the centre of the Medicas Onco AI vision is the Living Digital Twin — a continuously evolving, unified representation of the patient's clinical journey.

It is intended to connect relevant information across diagnosis, investigations, treatment, molecular and genomic findings, and ongoing care.

The concept addresses a fundamental challenge in oncology: patient information is often distributed across multiple records, systems and stages of treatment. A connected representation aims to make that information easier to review in its wider clinical context.

The objective is to move from fragmented information towards a more connected understanding of the patient over time.

AI Designed Around Clinical Practice

For Medicas, the opportunity is not simply to introduce AI into healthcare. It is to develop AI around the way oncology teams actually work.

That means considering the full clinical journey — from reviewing patient records and discussing complex cases to exploring clinical trial opportunities and supporting ongoing care.

The approach places the oncology team at the centre. AI can help organise information and support workflows, while clinical interpretation, decisions and patient management remain the responsibility of qualified healthcare professionals.

Watch Dr. Hari Explain the Vision

In the video, Dr. Parameswaran Hari discusses the growing complexity of cancer care, the role AI could play in connecting clinical information, and the thinking behind the Medicas Onco AI platform.

One Platform. Every Oncology Workflow. One Living Digital Twin.

Medicas Onco AI represents a vision for a more connected oncology ecosystem — one in which clinical information, workflows and insights can work together to support oncology teams as they navigate increasingly complex cancer care.

As the platform evolves, the focus remains on building AI around clinical workflows, supporting multidisciplinary collaboration and helping teams make better use of the information available to them.

Medicas Onco AI is intended to support clinical workflows and healthcare professionals. It does not replace professional medical judgement or the treating clinician's responsibility for patient care.

Stay Updated

Subscribe to our newsletter to receive the latest news, updates, and insights from EGS Health.

Subscribe Now